-
Tuesday 9th December 2014
To download the final programme, please click on the icon on the right hand side.
Plenary Session 3
Treatment of HCV in mono-infected patients
Professor Jean-Michel Pawlotsky, Hôpital Henri Mondor, Paris, France
Treatment of HCV in co-infected patients
Professor Douglas Dieterich, Mount Sinai Medical Center, NYC, USA
Plenary Session 4
What’s new in hepatitis B/HIV co-infection?
Professor Vincent Soriano, Hospital Carlos III, Madrid, Spain
Will hepatitis B become a curable disease?
Dr Patrick Kennedy, The Royal London Hospital, UK
Plenary Session 5
Hepatitis D in HIV
Dr Kate Childs, King’s College Hospital NHS Foundation Trust, London, UK
Acute hepatitis C
Dr Emma Page, Leeds Teaching Hospitals Trust, UK
What is in the pipeline?
AbbVie Ltd
Dr Alice Butler
Bristol-Myers Squibb Pharmaceuticals Ltd
Dr Adyb Baakili
Gilead Sciences International Ltd
Dr Cham Herath
Janssen
Dr Jonty Manuja
MSD Ltd
Dr Andrew Wilfin
Plenary Session 6 - HIV/hepatitis in Europe: who, when and where
United Kingdom
Professor Caroline Sabin, Royal Free and University College Medical School, London, UK
France
Professor Lionel Piroth, CHU Dijon, France
Germany
Dr Christoph Boesecke, University of Bonn, Germany
Italy
Professor Gloria Taliani, Sapienza University of Rome, Italy
Spain
Dr Juan Pineda, Hospital Universitario de Valme, Sevilla, Spain
European AIDS Treatment Group (EATG)
Mr Diego Garcia Morcillo, European AIDS Treatment Group (EATG), Spain
Debate: Re-infections should not be retreated
For the motion
Dr Robert James, Birchgrove, UK
Against the motion
Mr Luís Mendão, European AIDS Treatment Group (EATG), Portugal
Debate: F2–F3 fibrosis: treat now
For the motion
Professor Jürgen Rockstroh, University of Bonn, Germany
Against the motion
Dr Mark Nelson, Chelsea and Westminster Hospital, London, UK
Close
Dr Ranjababu Kulasegaram
Chair, Five Nations Conference Steering Committee